Prevention of cardiovascular adverse events by clopidogrel in coronary intervention Curative effect analysis
Journal: Preventive Medicine Research (Vol.4, No. 1)Publication Date: 2015-12-31
Authors : Liu liangming;
Page : 1-3
Keywords : Clopidogrel; Bad Cardiovascular; coronary heart disease; Interventional Therapy;
Abstract
Investigate the clinical effect of clopidogrel in the prevention of cardiovascular adverse events in interventional therapy of coronary heart disease . method Select my house 2015 year 9 Month ~2017 year 8 Monthly treatment of coronary heart disease in patients with a total of Example as the object of this study , According to the patient's visit time divide it equally into control groups and observation groups , each group each patients , control group patients underwent routine cardiology treatment , "" , Observation Group to take Clopidogrel and a "" Forest , for preventive treatment , The patient's cardiovascular indicators should be tracked , Understanding Clinical effects . Results Significant differences in coagulation observation results (P <0.05 , take medicine 6H Post-observation group B 2 The level is significantly lower than the control group , Postoperative 6 the incidence of cardiovascular adverse events in the month observation group is lower than the control Group , difference significant (P<0.05), statistically significant . Conclusion The use of Clopidogrel does not adversely
affect the treatment of patients with coronary heart disease. , do not cause condensation Blood dysfunction , for improving platelet aggregation Important effects of,, lowering postoperative cardiovascular events, etc. , has clinical extension value .
Other Latest Articles
- Potato chip external application prevention and treatment Observation on the effect of swelling and induration after vaccination
- Observation on the efficacy of pneumatic therapeutic apparatus in preventing deep venous thrombosis of lower extremity in long-bed elderly patients
- Balanced acid-base therapy for the prevention and treatment of diabetic cardio-cerebrovascular disease
- Molecular targeting drugs for treatment of lung cancer patientsPrevention of adverse skin reactions and their care
- Preventive application of liver-protecting drugs in the treatment of pulmonary tuberculosis
Last modified: 2020-03-16 15:00:55